Oral recombinant human insulin(Rani Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOral recombinant human insulin(Rani Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugsBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants

TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRani Therapeutics Llc

China Registration ClassN/A

Develop Information

Active CompaniesRani Therapeutics Llc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus

Inactive IndicationsN/A

Other Information

ATC CodeN/A